Riskpilot← Back to searchSign inGet full accessTonimed AB
ABActiveOrg 5569969024Storgatan 22 AGeneral medical practice activities · NACE 8621Est. 20141 employees
Revenue 2024
SEK 735K
EBITDA margin
45.3%
+1079% vs 2023
Equity ratio
8.4%
Financial strength
Net profit 2024
SEK 197K
+361% vs 2023
| Revenue | SEK 735K | — |
| EBITDA | SEK 332K | +1079% |
| Net profit | SEK 197K | +361% |
| Total assets | SEK 1,4M | +757% |
| Equity | SEK 116K | +138% |
| Employees | 1 | — |
Legal name
Tonimed AB
Org number
5569969024
Legal form
Aktiebolag
NACE code
8621 · General medical practice activities
Founded
17 december 2014
Share capital
SEK 50 000
Employees
1 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas ensam av Wilhelmsson-Macleod, Niklas P H
Company purpose
Medicinska konsultuppdrag (ibland med musikmedicinsk inriktning) och därmed förenlig verksamhet.
Address
Storgatan 22 A
Email
wilhelmsson.niklas@gmail.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 0 | 0 | 5 | 0 | 735 |
| Staff expenses | — | — | — | — | −39 |
| EBITDA | −1 | −12 | −10 | −34 | 332 |
| Depreciation & amort. | −0 | −0 | — | −40 | −118 |
| EBIT | −1 | −12 | −10 | −74 | 215 |
| Net financials | — | — | −0 | −1 | −0 |
| Profit before tax | −2 | −12 | −10 | −76 | 214 |
| Tax | −0 | −0 | — | — | −17 |
| Net profit | −2 | −12 | −10 | −76 | 197 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 30 | 30 | 41 | 161 | 1 381 |
| Equity | 16 | 29 | 39 | 49 | 116 |
| Long-term debt | 0 | 0 | — | — | — |
| Short-term debt | 13 | 0 | 2 | 112 | 1 265 |
| Total debt | 13 | — | 2 | 112 | 1 265 |
EBITDA margin
45.3%
This company
15.8%
Market median
+187% vs market
20202024
Equity ratio
8.4%
This company
38.2%
Market median
-78% vs market
20202024
Return on equity
170.0%
This company
18.4%
Market median
+824% vs market
20202024
Net profit margin
26.9%
This company
8.1%
Market median
+232% vs market
20202024
Asset turnover
0.53×
This company
1.12×
Market median
-53% vs market
20202024
Debt / equity
10.90×
This company
0.62×
Market median
-1658% vs market
20202024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (4) | ||
| Deputy Board Member | 2022 | |
| Board of Directors | 2022 | |
| Chairman | 2022 | |
| Board of Directors | 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Tonimed AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Marie Louise Wilhelmsson-Macleod | Deputy Board Member | 0 companies |
| Karin Elisabet Wilhelmsson | Board of Directors | 0 companies |
| Niklas P H Wilhelmsson-Macleod | Chairman | 0 companies |
| Håkan Emanuel Wilhelmsson | Board of Directors | 0 companies |